| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Research and development | $4.1M+14.5% | $3.5M-14.4% | $4.1M-22.9% | $5.4M-22.2% | $6.9M | — |
| General and administrative | $5.0M+13.1% | $4.4M-1.9% | $4.5M-17.8% | $5.5M+9.0% | $5.0M+3361.2% | $145K |
| Total operating expenses | $9.1M+13.7% | $8.0M-7.9% | $8.7M-20.3% | $10.9M-9.1% | $12.0M+8313.8% | -$145K |
| Loss from operations | -$9.1M-13.7% | -$8.0M+7.9% | -$8.7M+20.3% | -$10.9M+9.1% | -$12.0M-8113.8% | -$145K |
| Change in fair value of warrant liability | $2K-97.4% | $81K-99.0% | $8.3M | $0 | — | -$1.5M |
| Other income (expense), net | $155K+102.2% | -$7.1M-3543.8% | $207K+493.4% | $35K+196.2% | -$36K+97.6% | -$1.5M |
| Total other income (expense), net | $157K+102.2% | -$7.1M-182.7% | $8.5M+24316.3% | $35K+196.2% | -$36K | — |
| Net loss | -$8.9M+40.7% | -$15.0M-12405.6% | -$120K+98.9% | -$10.8M+9.7% | -$12.0M-635.2% | -$1.6M |
| Deemed dividends | -$6.0M | — | — | — | — | — |
| Net loss attributable to common stockholders | -$14.9M+1.2% | -$15.0M | — | — | — | — |
| Net loss per share, basic | -$23.95+97.7% | -$1052.16-12366.4% | -$8.44+94.3% | -$149.20-251.1% | -$42.50-6150.0% | -$0.68 |
| Net loss per share, diluted | -$23.95+97.7% | -$1052.16-12366.4% | -$8.44+94.3% | -$149.20-251.1% | -$42.50 | — |
| Weighted-average shares used to compute net loss per share, basic | $620785.00+4243.3% | $14293.00+0.3% | $14246.00-80.4% | $72585.00-74.3% | $282035.00-88.3% | $2409951.00 |
| Weighted-average shares used to compute net loss per share, diluted | $620785.00+4243.3% | $14293.00+0.3% | $14246.00-80.4% | $72585.00-74.3% | $282035.00 | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.